Robin Washington, Senior Vice President and CFO, Gilead Sciences Robin Washington (right), Senior Vice President and CFO, and Dennis Self, Vice President and CIO, Gilead Sciences Gilead's product line is expanding to include treatments for oncological and inflammation diseases and Hepatitis C. Dennis Self, Vice President and CIO, Gilead Sciences